Funding for this research was provided by:
Medizinische Universität Wien
Received: 6 January 2020
Accepted: 23 April 2020
First Online: 12 May 2020
Ethics approval and consent to participate
: This article contains human participants as respondent to the survey. The study was approved by the Ethic committee of the Medical University Vienna (EK 1614/2017) and written informed consent was given by all participants.
: All included figures are entirely unidentifiable and there are no details on individuals reported within the manuscript. The survey was performed completely anonymous.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.Anna Sophie Berghoff has research support from Daiichi Sankyo and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Meyers Squibb, Merck, Daiichi Sankyo as well as travel support from Roche, Amgen and AbbVie.Matthias Preusser has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Merck Sharp & Dome.Amélie Darlix has received travel support from Roche, Amgen and Chugai.Christian F. Freyschlag received honoraria for lectures, consultation or advisory board participation from AbbVie, BrainLab, Novocure, proMed Instruments, Roche, Zeiss as well as travel support from Roche and Novocure.All others indicate no conflicts of interests.